Clinical Cancer Research

NIVOLUMAB IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: EFFICACY AND SAFETY IN CHECKMATE 141 BY PRIOR CETUXIMAB USE

Robert L Ferris, Lisa Licitra, Jerome Fayette, Caroline Even, George Blumenschein Jr, et al. Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use. Clin Cancer Res. 2019 Sep 1;25(17):5221-5230. DOI: 10.1158/1078-0432.CCR-18-3944. Epub 2019 Jun 25. Cetuximab, modula las respuestas inmunitarias y puede afectar […]